
Deepmalik Pharmaceutical (Opc) Private Limited
Founded in 2024 and headquartered in Haryana, India.
Founded in 2024 and headquartered in Haryana, India.
Deepmalik Pharmaceutical (Opc) Private Limited (DPOPL) is a Company incorporated in India on 04 March 2024 (One year and two months 17 days old ). Its registered office is in Gurugram, Haryana, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active It's a company limited by shares with an authorized capital of Rs 0.20 M and a paid-up capital of Rs 10.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sandeep Kumar serves as a director at the Company.
Gurugram, Haryana, India
+91-XXXXXXXXXX
U47720HR2024OPC119492
119492
04 Mar 2024
-
-
Unlisted
Roc Delhi
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sandeep Kumar ![]() | Director | 04-Mar-2024 | Current |
Enhance accessibility to Deepmalik Pharmaceutical (Opc)'s financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Deepmalik Pharmaceutical (Opc)'s control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Sandeep Kumar is a mutual person
Sandeep Kumar is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Deepmalik Pharmaceutical (Opc), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Deepmalik Pharmaceutical (Opc), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deepmalik Pharmaceutical (Opc)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sandeep Kumar was appointed as a Director was appointed as a Director on 04 Mar 2024 & has been associated with this company since 1 year 2 months .
Deepmalik Pharmaceutical (Opc) Private Limited was registered on 04 Mar 2024 with Roc Delhi & aged 1 year 2 months as per MCA records.
Deepmalik Pharmaceutical (Opc) Private Limited was incorporated on 04 Mar 2024.
The authorized share capital of Deepmalik Pharmaceutical (Opc) Private Limited is ₹ 0.20 M and paid-up capital is ₹ 10.00 K .
Currently 1 director is associated with Deepmalik Pharmaceutical (Opc) Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Deepmalik Pharmaceutical (Opc) Private Limited is Basement Plot No 527 Saini Plaza, Vill Choma India, Palam Vihar, Haryana, 122017.
The corporate identification number (CIN) of Deepmalik Pharmaceutical (Opc) Private Limited is U47720HR2024OPC119492 and the company number is 119492 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.